Prevalence and impact of respiratory symptoms in a population of patients with COPD in Latin America: The LASSYC observational study

被引:11
作者
Miravitlles, Marc [1 ]
Menezes, Ana [2 ]
Lopez Varela, Maria Victorina [3 ]
Casas, Alejandro [4 ]
Ugalde, Luis [5 ]
Ramirez-Venegas, Alejandra [6 ]
Mendoza, Laura [7 ]
Lopez, Ana [8 ]
Wehrmeister, Fernando C. [2 ]
Surmont, Filip [9 ]
Montes de Oca, Maria [10 ]
机构
[1] Hosp Univ Vall dHebron, Dept Pneumol, CIBER Enfermedades Resp CIBERES, Barcelona, Spain
[2] Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, Brazil
[3] Univ Republica, Montevideo, Uruguay
[4] Univ Rosario, Fdn Neumol Colombiana, Bogota, Colombia
[5] Clin Amer, San Jose, Costa Rica
[6] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Mexico City, DF, Mexico
[7] Hosp Clin Univ Chile, Santiago, Chile
[8] Hosp Privado Univ Cordoba, Cordoba, Argentina
[9] AstraZeneca, Wilmington, DE USA
[10] Univ Cent Venezuela, Hosp Univ Caracas, Caracas, Venezuela
关键词
Symptoms; Quality of life; Exacerbations; Latin America; OBSTRUCTIVE PULMONARY-DISEASE; ACUTE EXACERBATIONS; LUNG-FUNCTION; VARIABILITY; MORTALITY; GUIDELINES; MANAGEMENT; DYSPNEA; BURDEN; CITIES;
D O I
10.1016/j.rmed.2017.11.018
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Background: To analyse the relationship between symptoms at different times during the 24-hour day and outcomes in COPD. Methods: Observational cross-sectional study in a patients from 7 Latin American countries. The frequency of symptoms in the morning, at night and during the day was explored by means of standardised and validated questionnaires, and the relationship between symptoms and exacerbations and quality of life were investigated. Results: 734 patients (59.6% male, mean age 69.5 years, mean FEV1 50% predicted normal) were recruited. The most frequent symptoms during the day were dyspnea (75% of patients, of which 94% mild-moderate) and cough (72.2%, of which 93.4% mild-moderate). Highly symptomatic patients had a greater impairment in FEV1, more exacerbations and worse scores in COPD assessment test (CAT) and Body Mass Index, Obstruction, Dyspnoea and Exacerbations (BODEx) index (all p < 0.001). Morning symptoms were more frequent than night-time symptoms, particularly cough and dyspnoea (morning: 50.1% and 45.7%; night-time: 33.2% and 24.4%, respectively), and mostly rated as mild or moderate. Patients with morning or night-time symptoms presented with worse severity of daytime symptoms. There was a strong correlation between intensity of daytime with morning or night-time symptoms, as well as with CAT score (r = 0.715; p < 0.001), but a weak correlation with FEV1 (r = -0.205; p < 0.001). Conclusion: Morning symptoms were more frequent than night-time symptoms, and having either morning and/or night-time symptoms was associated with worse severity of daytime symptoms. Increased symptoms were strongly associated with worse quality of life and more frequent exacerbations, but weakly associated with airflow limitation.
引用
收藏
页码:62 / 69
页数:8
相关论文
共 38 条
[1]
Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease [J].
Bestall, JC ;
Paul, EA ;
Garrod, R ;
Garnham, R ;
Jones, PW ;
Wedzicha, JA .
THORAX, 1999, 54 (07) :581-586
[2]
Prevalence of COPD in five Colombian cities situated at low, medium, and high altitude (PREPOCOL study) [J].
Caballero, Andres ;
Torres-Duque, Carlos A. ;
Jaramillo, Claudia ;
Bolivar, Fabio ;
Sanabria, Fernando ;
Osorio, Patricia ;
Orduz, Carlos ;
Guevara, Diana P. ;
Maldonado, Dario .
CHEST, 2008, 133 (02) :343-349
[3]
Adherence to inhaled therapies of COPD patients from seven Latin American countries: The LASSYC study [J].
de Oca, Maria Montes ;
Menezes, Ana ;
Wehrmeister, Fernando C. ;
Lopez Varela, Maria Victorina ;
Casas, Alejandro ;
Ugalde, Luis ;
Ramirez-Venegas, Alejandra ;
Mendoza, Laura ;
Lopez, Ana ;
Surmont, Filip ;
Miravitlles, Marc .
PLOS ONE, 2017, 12 (11)
[4]
Comorbidities and Risk of Mortality in Patients with Chronic Obstructive Pulmonary Disease [J].
Divo, Miguel ;
Cote, Claudia ;
de Torres, Juan P. ;
Casanova, Ciro ;
Marin, Jose M. ;
Pinto-Plata, Victor ;
Zulueta, Javier ;
Cabrera, Carlos ;
Zagaceta, Jorge ;
Hunninghake, Gary ;
Celli, Bartolome .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2012, 186 (02) :155-161
[5]
Health-related QOL in acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease: A review of the literature [J].
Doll, H ;
Miravitlles, M .
PHARMACOECONOMICS, 2005, 23 (04) :345-363
[6]
Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease [J].
Dransfield, Mark T. ;
Kunisaki, Ken M. ;
Strand, Matthew J. ;
Anzueto, Antonio ;
Bhatt, Surya P. ;
Bowler, Russell P. ;
Criner, Gerard J. ;
Curtis, Jeffrey L. ;
Hanania, Nicola A. ;
Nath, Hrudaya ;
Putcha, Nirupama ;
Roark, Sarah E. ;
Wan, Emily S. ;
Washko, George R. ;
Wells, J. Michael ;
Wendt, Christine H. ;
Make, Barry J. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195 (03) :324-330
[7]
Eremenco S, 2014, VALUE HEALTH, V17, pA600, DOI 10.1016/j.jval.2014.08.2080
[8]
Chronic obstructive pulmonary disease stage and health-related quality of life [J].
Ferrer, M ;
Alonso, J ;
Morera, J ;
Marrades, RM ;
Khalaf, A ;
Aguar, MC ;
Plaza, V ;
Prieto, L ;
Antó, JM .
ANNALS OF INTERNAL MEDICINE, 1997, 127 (12) :1072-1079
[9]
The development of a patient-reported outcome measure for assessing nighttime symptoms of chronic obstructive pulmonary disease [J].
Hareendran, Asha ;
Palsgrove, Andrew C. ;
Mocarski, Michelle ;
Schaefer, Michael L. ;
Setyawan, Juliana ;
Carson, Robyn ;
Make, Barry .
HEALTH AND QUALITY OF LIFE OUTCOMES, 2013, 11
[10]
Development and first validation of the COPD Assessment Test [J].
Jones, P. W. ;
Harding, G. ;
Berry, P. ;
Wiklund, I. ;
Chen, W-H. ;
Leidy, N. Kline .
EUROPEAN RESPIRATORY JOURNAL, 2009, 34 (03) :648-654